Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19

Authors:

Abstract
No abstract available
Funding Information
  • Japan Agency for Medical Research and Development

This publication has 13 references indexed in Scilit: